Sign inJoin waitlistJoin the waitlist

Back to Duke University Hospital Hematology and Medical Oncology

ZH

Zachary Hing

Hematology and Medical Oncology Fellow · Duke University Hospital

Credentials: · · ·

History

Hematology and Medical Oncology
Duke University Hospital
2025–Present
Hematology and Medical Oncology Fellow
Duke University Hospital
Present
University of Pennsylvania
2020–2023
Ohio State Univ Coll of Med
2016–2020

Research

Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies
Leukemia · 2016 · First of 22 authors · 125 citations
BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor
Cancer Discovery · 2018 · 116 citations
Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemia
Blood · 2015 · First of 12 authors · 78 citations

JB
John Byrd
8 papers
Jennifer Woyach
7 papers
James Blachly
3 papers
KR
Kerry Rogers
2 papers
Lapo Alinari
2 papers
Nicole Grieselhuber
2 papers
Robert Baiocchi
2 papers
Rose Mantel
2 papers
Steven Sher
2 papers
Adam Blaisdell
1 paper
Avital Perry
1 paper
Bradley Blaser
1 paper